LIFECORE BIOMEDICAL, INC. \DE\ Cash Flow Statement
LFCR|8 years of annual SEC 10-K data (FY2012-FY2019)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 8 fiscal years. All figures from audited SEC 10-K filings.
LIFECORE BIOMEDICAL, INC. \DE\ generated $30M in operating cash flow and $7M in free cash flow in FY2019. Free cash flow margin was 1.3% of revenue.
Based on SEC 10-K filings.
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|---|---|
| Net Income | $10.6M | -$11.6M | $2.4M | $19.1M | $22.6M | $12.7M | $3.9M | $4.0M |
| Depreciation & Amortization | $10.7M | $9.4M | $7.1M | $7.1M | $7.3M | $5.6M | $5.3M | $3.4M |
| Operating Cash Flow | $29.8M | $20.8M | $26.6M | $21.0M | $21.2M | $22.2M | $14.5M | $7.5M |
| Capital Expenditures | $23.0M | $39.7M | $17.5M | $14.9M | $8.9M | $5.4M | $6.7M | $5.2M |
| Free Cash Flow | $6.8M | -$18.9M | $9.1M | $6.2M | $12.4M | $16.8M | $7.8M | $2.3M |
| Share Buybacks | - | - | - | - | - | $5.0M | $1.2M | $1.2M |
| FCF Margin | 1.3% | -4.0% | 1.7% | 1.3% | 2.8% | 5.3% | 2.8% | 1.0% |